A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome

NCT03899337 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Richter Syndrome

Interventions

DRUG: Acalabrutinib
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisolone
DRUG: Rituximab

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]